Causes of death in a contemporary cohort of patients with invasive aspergillosis

dc.contributor.authorGarcia Vidal, Carolina
dc.contributor.authorPeghin, Maddalena
dc.contributor.authorCervera, Carlos
dc.contributor.authorGudiol González, Carlota
dc.contributor.authorRuiz, Isabel (Ruiz Camps)
dc.contributor.authorMoreno Camacho, Ma. Asunción
dc.contributor.authorRoyo-Cebrecos, Cristina
dc.contributor.authorRoselló, Eva
dc.contributor.authorPuig de la Bellacasa, Jordi
dc.contributor.authorAyats, Josefina
dc.contributor.authorCarratalà, Jordi
dc.date.accessioned2017-07-12T10:36:16Z
dc.date.available2017-07-12T10:36:16Z
dc.date.issued2015-03-24
dc.date.updated2017-07-12T10:36:16Z
dc.description.abstractInformation regarding the processes leading to death in patients with invasive aspergillosis (IA) is lacking. We sought to determine the causes of death in these patients, the role that IA played in the cause, and the timing of death. The factors associated with IA-related mortality are also analyzed. We conducted a multicenter study (2008-2011) of cases of proven and probable IA. The causes of death and whether mortality was judged to be IA-related or IA-unrelated were determined by consensus using a six-member review panel. A multivariate analysis was performed to determine risk factors for IA-related death. Of 152 patients with IA, 92 (60.5%) died. Mortality was judged to be IA-related in 62 cases and IA-unrelated in 30. The most common cause of IA-related death was respiratory failure (50/62 patients), caused primarily by Aspergillus infection, although also by concomitant infections or severe comorbidities. Progression of underlying disease and bacteremic shock were the most frequent causes of IA-unrelated death. IA-related mortality accounted for 98% and 87% of deaths within the first 14 and 21 days, respectively. Liver disease (HR 4.54; 95% CI, 1.69-12.23) was independently associated with IA-related mortality, whereas voriconazole treatment was associated with reduced risk of death (HR 0.43; 95% CI, 0.20-0.93). In conclusion, better management of lung injury after IA diagnosis is the main challenge for physicians to improve IA outcomes. There are significant differences in causes and timing between IA-related and IA-unrelated mortality and these should be considered in future research to assess the quality of IA care
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec669802
dc.identifier.issn1932-6203
dc.identifier.pmid25803853
dc.identifier.urihttps://hdl.handle.net/2445/113706
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0120370
dc.relation.ispartofPLoS One, 2015, vol. 10, num. 3, p. e0120370
dc.relation.urihttps://doi.org/10.1371/journal.pone.0120370
dc.rightscc-by (c) Garcia Vidal, Carolina et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationInfeccions respiratòries
dc.subject.classificationPacients
dc.subject.classificationMalalties del fetge
dc.subject.classificationCauses de la mort
dc.subject.classificationAspergil·losi
dc.subject.otherRespiratory infections
dc.subject.otherPatients
dc.subject.otherLiver diseases
dc.subject.otherCauses of death
dc.subject.otherAspergillosis
dc.titleCauses of death in a contemporary cohort of patients with invasive aspergillosis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
669802.pdf
Mida:
548.44 KB
Format:
Adobe Portable Document Format